Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Pharming Articles

US FDA accepts Ruconest filing from Santarus and Pharming

18 June 2013

Pharming and Santarus file BLA for Ruconest with US FDA

18 April 2013

Pharming gets $10 million milestone from Santarus on Ruconest progress

26 November 2012

Pharming first-half 2012 net loss nearly doubles

24 August 2012

Pharming considers options, including a sale of the company

13 June 2012

Pharming in deal with Hyupjin for Ruconest in South Korea

27 March 2012

Pharming extends Ruconest deal with SOBI

16 August 2011

Pharming’s Ruconest efficacy backed in new trial

24 May 2011

FDA turns down 'incomplete' Rhucin dossier

1 March 2011

Pharming licenses North American rights to HAE drug Rhucin to Santarus for upfront $15 million

14 September 2010

Pharming plans to file Rhucin BLA with US FDA by end 2010

31 August 2010

Batch of positive opinions from Europe's Committee for Medicinal Products for Human Use recent meetings

28 June 2010

Dutch firm Pharming initiates DNage divestment, to focus on Rhucin

18 May 2010

Showing 1-13 of 13 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS